|
A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients
RECRUITINGPhase 4Sponsored by Mayo Clinic
Actively Recruiting
PhasePhase 4
SponsorMayo Clinic
Started2026-09-14
Est. completion2027-12
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07424625
Summary
The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.
Eligibility
Age: 21 Years+Healthy volunteers accepted
* Inclusion criteria * Cardiothoracic surgery with use of cardiopulmonary bypass * Presence of metabolic acidosis (defined as a base excess of \<-5) * Minnesota Research Authorization * Exclusion criteria * Non-cardiac surgery patients or cardiac surgery without cardiopulmonary bypass * Absence of metabolic acidosis (metabolic acidosis being defined as a base excess of \<-5) * Pregnant patients * Prisoners * Opt out of Minnesota Research Authorization
Conditions2
Heart DiseaseMetabolic Acidosis
Interventions2
Locations1 site
Find trials near these locations
Related trials
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD — University of California, Davis
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorMayo Clinic
Started2026-09-14
Est. completion2027-12
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07424625